S&P 500 Futures
(0.20%) 5 142.00 points
Dow Jones Futures
(0.20%) 38 518 points
Nasdaq Futures
(0.29%) 17 897 points
Oil
(-0.93%) $83.07
Gas
(1.56%) $1.953
Gold
(-0.34%) $2 339.20
Silver
(-1.33%) $27.17
Platinum
(0.27%) $924.60
USD/EUR
(-0.13%) $0.933
USD/NOK
(-0.09%) $11.01
USD/GBP
(-0.20%) $0.799
USD/RUB
(0.86%) $92.66

Echtzeitaktualisierungen für Tianda Pharmaceuticals [0455.HK]

Börse: HKSE Sektor: Healthcare Industrie: Drug Manufacturers—Specialty & Generic
Zuletzt aktualisiert29 Apr 2024 @ 03:48

0.00% HKD 0.265

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 03:48):

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia...

Stats
Tagesvolumen 10 000.00
Durchschnittsvolumen 395 016
Marktkapitalisierung 569.76M
EPS HKD0 ( 2023-08-28 )
Last Dividend HKD0.00260 ( 2023-06-29 )
Next Dividend HKD0 ( N/A )
P/E -26.50
ATR14 HKD0 (0.00%)

Tianda Pharmaceuticals Korrelation

10 Am meisten positiv korreliert
10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Tianda Pharmaceuticals Finanzdaten

Annual 2023
Umsatz: HKD532.09M
Bruttogewinn: HKD255.53M (48.02 %)
EPS: HKD-0.0112
FY 2023
Umsatz: HKD532.09M
Bruttogewinn: HKD255.53M (48.02 %)
EPS: HKD-0.0112
FY 2022
Umsatz: HKD546.69M
Bruttogewinn: HKD251.52M (46.01 %)
EPS: HKD-0.0254
FY 2022
Umsatz: HKD509.96M
Bruttogewinn: HKD241.22M (47.30 %)
EPS: HKD-0.0101

Financial Reports:

No articles found.

Tianda Pharmaceuticals Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.0112
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.00260
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

Tianda Pharmaceuticals Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.25 - low (41.27%) | Divividend Growth Potential Score: 0 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.00450 2010-07-23
Last Dividend HKD0.00260 2023-06-29
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 14 --
Total Paid Out HKD0.0530 --
Avg. Dividend % Per Year 0.00% --
Score 1.23 --
Div. Sustainability Score 4.25
Div.Growth Potential Score 0
Div. Directional Score 1.955 --
Next Divdend (Est)
(2024-05-07)
HKD0.00229 Estimate 3.07 %
Dividend Stability
0.25 Very Poor
Dividend Score
1.23
Pay Frequency
Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
3808.HK Ex Dividend Junior 2023-07-04 Annually 0 0.00%
1696.HK Ex Dividend Junior 2023-08-24 Annually 0 0.00%
0730.HK Ex Dividend Junior 2023-05-24 Annually 0 0.00%
2283.HK Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
1270.HK Ex Dividend Knight 2023-05-16 Annually 0 0.00%
0323.HK No Dividend Player 2023-06-21 Sporadic 0 0.00%
6055.HK Ex Dividend Knight 2023-06-13 Annually 0 0.00%
1821.HK Ex Dividend Junior 2023-09-07 Semi-Annually 0 0.00%
0856.HK Ex Dividend Junior 2023-05-31 Annually 0 0.00%
0010.HK Ex Dividend Knight 2023-09-12 Semi-Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.04541.500-0.908-1.362[0 - 0.5]
returnOnAssetsTTM-0.02631.200-0.878-1.053[0 - 0.3]
returnOnEquityTTM-0.04051.500-1.561-2.34[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM1.0990.8009.517.61[1 - 3]
quickRatioTTM0.8540.8009.687.75[0.8 - 2.5]
cashRatioTTM0.5181.5008.2310.00[0.2 - 2]
debtRatioTTM0.120-1.5007.99-10.00[0 - 0.6]
interestCoverageTTM-5.451.000-3.13-3.13[3 - 30]
operatingCashFlowPerShareTTM-0.02412.00-0.00802-0.0160[0 - 30]
freeCashFlowPerShareTTM-0.04242.00-0.0212-0.0424[0 - 20]
debtEquityRatioTTM0.187-1.5009.25-10.00[0 - 2.5]
grossProfitMarginTTM0.4801.0005.335.33[0.2 - 0.8]
operatingProfitMarginTTM-0.05451.000-3.09-3.09[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.4681.000-3.71-3.71[0.2 - 2]
assetTurnoverTTM0.5800.8009.477.57[0.5 - 2]
Total Score4.25

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-23.591.000-2.480[1 - 100]
returnOnEquityTTM-0.04052.50-1.003-2.34[0.1 - 1.5]
freeCashFlowPerShareTTM-0.04242.00-0.0141-0.0424[0 - 30]
dividendYielPercentageTTM0.9811.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM-0.02412.00-0.00802-0.0160[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.1561.500-2.300[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.09721.000-4.930[0.1 - 0.5]
Total Score-0.341

Tianda Pharmaceuticals

Tianda Pharmaceuticals Limited, an investment holding company, engages in the research and development, production, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia. Its product range includes Chinese medicines, chemical drugs, biological and health products, and medical appliances covering the area of cardio-cerebrovascular, pediatric, anti-flu and respiratory, anti-infection, detoxification, urological agents, and others. The company offers its health products under the Herb Valley and Tuokang brands. It also engages in the sale and wholesale of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicines; provision of Chinese medical services; and trading of agricultural by-products. The company was formerly known as Tianda Holdings Limited and changed its name to Tianda Pharmaceuticals Limited in September 2012. The company was incorporated in 1992 and is headquartered in Central, Hong Kong. Tianda Pharmaceuticals Limited is a subsidiary of Tianda Group Limited.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.